Jin Y - Search Results

1

Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non-Small Cell Lung Cancer.

Lin C, Shi X, Zhao J, He Q, Fan Y, Xu W, Shao Y, Yu X, Jin Y. Lin C, et al. Among authors: jin y. Front Oncol. 2020 Apr 29;10:480. doi: 10.3389/fonc.2020.00480. eCollection 2020. Front Oncol. 2020. PMID: 32411590 Free PMC article.

2

Meta-analysis to assess the efficacy and toxicity of docetaxel-based doublet compared with docetaxel alone for patients with advanced NSCLC who failed first-line treatment.

Jin Y, Sun Y, Shi X, Zhao J, Shi L, Hong W, Yu X. Jin Y, et al. Clin Ther. 2014 Dec 1;36(12):1980-1990. doi: 10.1016/j.clinthera.2014.08.015. Epub 2014 Sep 23. Clin Ther. 2014. PMID: 25256387

3

Prognostic value of circulating C-reactive protein levels in patients with non-small cell lung cancer: a systematic review with meta-analysis.

Jin Y, Sun Y, Shi X, Zhao J, Shi L, Yu X. Jin Y, et al. J Cancer Res Ther. 2014 Nov;10 Suppl:C160-6. doi: 10.4103/0973-1482.145854. J Cancer Res Ther. 2014. PMID: 25450276 Free article.

4

Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis.

Jin Y, Zhao J, Shi X, Yu X. Jin Y, et al. J Cancer Res Ther. 2015 Aug;11 Suppl 1:C38-43. doi: 10.4103/0973-1482.163837. J Cancer Res Ther. 2015. PMID: 26323922 Free article.

5

Differences among lesions with exon 19, exon 21 EGFR mutations and wild types in surgically resected non-small cell lung cancer.

Jin Y, Chen M, Yu X. Jin Y, et al. Sci Rep. 2016 Aug 16;6:31636. doi: 10.1038/srep31636. Sci Rep. 2016. PMID: 27527915 Free PMC article.

6

Mutational profiling of non-small-cell lung cancer patients resistant to first-generation EGFR tyrosine kinase inhibitors using next generation sequencing.

Jin Y, Shao Y, Shi X, Lou G, Zhang Y, Wu X, Tong X, Yu X. Jin Y, et al. Oncotarget. 2016 Sep 20;7(38):61755-61763. doi: 10.18632/oncotarget.11237. Oncotarget. 2016. PMID: 27528220 Free PMC article.

7

Comparison of the 7(th) and proposed 8(th) editions of the AJCC/UICC TNM staging system for non-small cell lung cancer undergoing radical surgery.

Jin Y, Chen M, Yu X. Jin Y, et al. Sci Rep. 2016 Sep 19;6:33587. doi: 10.1038/srep33587. Sci Rep. 2016. PMID: 27641932 Free PMC article.

8

A real-world study of treatment patterns and survival outcome in advanced anaplastic lymphoma kinase-positive non-small-cell lung cancer.

Jin Y, Chen Y, Yu X, Shi X. Jin Y, et al. Oncol Lett. 2018 Jun;15(6):8703-8710. doi: 10.3892/ol.2018.8444. Epub 2018 Apr 5. Oncol Lett. 2018. PMID: 29805608 Free PMC article.

9

Clinicopathologic characteristics and survival outcome in patients with advanced lung adenocarcinoma and KRAS mutation.

Yang S, Yu X, Fan Y, Shi X, Jin Y. Yang S, et al. Among authors: jin y. J Cancer. 2018 Jul 30;9(16):2930-2937. doi: 10.7150/jca.24425. eCollection 2018. J Cancer. 2018. PMID: 30123361 Free PMC article.

10

Mechanisms of primary resistance to EGFR targeted therapy in advanced lung adenocarcinomas.

Jin Y, Shi X, Zhao J, He Q, Chen M, Yan J, Ou Q, Wu X, Shao YW, Yu X. Jin Y, et al. Lung Cancer. 2018 Oct;124:110-116. doi: 10.1016/j.lungcan.2018.07.039. Epub 2018 Jul 29. Lung Cancer. 2018. PMID: 30268447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,467 results

Search Page

Filters